elacestrant
Sign in to saveElacestrant, sold under the brand name Orserdu, is a selective estrogen receptor degrader (SERD) used in the treatment of breast cancer. It is taken by mouth.
Wikidata facts
- Mass
- 458.293
Show 3 more facts
- canonical SMILES
- CCNCCC1=CC=C(C=C1)CN(CC)C2=C(C=CC(=C2)OC)C3CCC4=C(C3)C=CC(=C4)O
- chemical formula
- C₃₀H₃₈N₂O₂
- isomeric SMILES
- CCNCCC1=CC=C(C=C1)CN(CC)C2=C(C=CC(=C2)OC)[C@@H]3CCC4=C(C3)C=CC(=C4)O
Sources (1)
via Wikidata · CC0
~6 min read
Article
7 sectionsContents
- Medical uses
- Pharmacology
- Pharmacodynamics
- Pharmacokinetics
- History
- Research
- References
{{Infobox drug | image = Elacestrant.svg | image_class = skin-invert-image | width = 225px
| pronounce = | tradename = Orserdu | Drugs.com = | MedlinePlus = | licence_CA = | licence_EU = | DailyMedID = Elacestrant | licence_US = | pregnancy_AU = | pregnancy_AU_comment = | pregnancy_category = | routes_of_administration = By mouth | class = | ATCvet = | ATC_prefix = L02 | ATC_suffix = BA04 | ATC_supplemental =
Connections
DDT
Entity
bioavailability
Entity
biological half-life
Entity
oral administration
Entity
(+)-catechin
Entity
abiraterone acetate
Entity
selective estrogen-receptor modulators
Entity
Miroestrol
Entity
ESR1
Gene
4-[(1R,2S)-1-ethyl-2-(4-hydroxyphenyl)butyl]phenol
Entity
brain
Entity
liver
Entity
bone
Entity
female breast
Entity
cadmium
Entity
urine
Entity
metabolism
Entity
uterus
Entity
feces
Entity
Wayback Machine
Entity